has reported Standalone financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 41.9071 crores during the period ended March 31, 2024 as compared to Rs. 30.0450 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 3.0991 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 1.4454 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 0.37 for the period ended March 31, 2024 as compared to Rs. 0.17 for the period ended December 31, 2023.
Total Income | ₹ 41.9071 crs | ₹30.0450 crs | 39.48% |
Net Profit | ₹3.0991 crs | ₹1.4454 crs | 114.41% |
EPS | ₹0.37 | ₹0.17 | 117.65% |
Financial Results (Q4 FY2024) - YoY Comparison The company has reported total income of Rs. 41.9071 crores during the period ended March 31, 2024 as compared to Rs.28.0337 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.3.0991 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.1.7657 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.0.37 for the period ended March 31, 2024 as compared to Rs.0.21 for the period ended March 31, 2023.
Total Income | ₹ 41.9071 crs | ₹28.0337 crs | 49.49% |
Net Profit | ₹3.0991 crs | ₹1.7657 crs | 75.52% |
EPS | ₹0.37 | ₹0.21 | 76.19% |
Financial Results (Year Ended FY2024) - YoY Comparison The company has reported total income of Rs.147.0491 crores during the Financial Year ended March 31, 2024 as compared to Rs.144.3841 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.8.2909 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.7.2415 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.1 for the Financial Year ended March 31, 2024 as compared to Rs.0.87 for the Financial Year ended March 31, 2023.
Total Income | ₹147.0491 crs | ₹144.3841 crs | 1.85% |
Net Profit | ₹8.2909 crs | ₹7.2415 crs | 14.49% |
EPS | ₹1 | ₹0.87 | 14.94% |
Source : Equity Bulls
Keywords
MedicoRemedies
Q4FY24
FY2024
ResultUpdate